KODKodiak Sciences Inc.
What is the market doing?
No clear lean: in an uptrend and insiders net buying, but a crowded short (+17% of shares).
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 88). Price is +174% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 8, 2026.
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How KOD is trading
Kodiak Sciences Inc. is +207% over the past year while the S&P 500 is +18%: 189 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +174%
vs 200-day average · a clear uptrend
- RSI (14)
- 88
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 0.00%
Below its 52-week high
Details›
- Last close2026-10-09
- $32.34
- 1 monthS&P 500 +2.7%
- −18%
- 1 yearS&P 500 +18%
- +207%
- 5 yearsS&P 500 +88%
- −66%
- vs 50-day average$48.99
- +104%
- 52-week high
- $99.91
- 52-week low
- $11.60
- Annualised volatility
- 172%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $157M
| Year | Return |
|---|---|
| 2026 (year to date) | +257% |
| 2025 | +181% |
| 2024 | +227% |
| 2023 | −58% |
| 2022 | −92% |
| 2021 | −42% |
| 2020 | +104% |
| 2019 | +913% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 3 of 8 | −7.7% |
| Feb | 8 | 4 of 8 | −9.4% |
| Mar | 8 | 1 of 8 | −7.7% |
| Apr | 8 | 5 of 8 | +1.7% |
| May | 8 | 4 of 8 | +4.7% |
| Jun | 8 | 5 of 8 | +1.5% |
| Jul | 8 | 5 of 8 | +9.1% |
| Aug | 8 | 4 of 8 | +0.73% |
| Sep | 8 | 6 of 8 | +31% |
| Oct | 8 | 6 of 8 | +19% |
| Nov | 8 | 6 of 8 | +30% |
| Dec | 8 | 5 of 8 | +27% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.